ALIGN TECHNOLOGY, INC. (ALGN) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.91B USD | Liabilities, Current |
| Cash and equivalents | 1.10B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 1.15B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 212.24M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.91B | $1.10B | (m) | $1.15B | $212.24M | (m) |
| 2026-03-31 | (m) | $1.91B | $1.06B | (m) | $1.13B | $214.94M | (m) |
| 2025-12-31 | (m) | $1.92B | $1.09B | (m) | $1.10B | $226.34M | (m) |
| 2025-09-30 | (m) | $1.97B | $1.00B | (m) | $1.10B | $228.16M | (m) |
| 2025-06-30 | (m) | $2.00B | $901.16M | (m) | $1.12B | $243.75M | (m) |
| 2025-03-31 | (m) | $1.99B | $873.01M | (m) | $1.06B | $246.57M | (m) |
| 2024-12-31 | $2.04B | $2.04B | $1.04B | $0.00 | $995.68M | $254.29M | 1.00× |
| 2024-09-30 | $2.05B | $2.06B | $1.04B | $0.00 | $1.01B | $254.12M | 0.99× |
| 2024-06-30 | $1.80B | $2.04B | $761.43M | $20.68M | $1.02B | $259.49M | 0.88× |
| 2024-03-31 | $1.85B | $2.02B | $865.80M | $33.10M | $950.74M | $280.08M | 0.91× |
| 2023-12-31 | $1.88B | $2.07B | $937.44M | $35.30M | $903.42M | $296.90M | 0.91× |
| 2023-09-30 | $2.19B | $2.12B | $1.24B | $44.79M | $904.18M | $296.19M | 1.03× |
| 2023-06-30 | $1.92B | $2.11B | $951.96M | $55.80M | $908.39M | $312.74M | 0.91× |
| 2023-03-31 | $1.77B | $2.00B | $832.38M | $51.64M | $884.43M | $311.88M | 0.88× |
| 2022-12-31 | $1.86B | $1.93B | $942.05M | $57.53M | $859.68M | $338.75M | 0.97× |
| 2022-09-30 | $1.95B | $1.81B | $1.04B | $46.24M | $859.63M | $320.90M | 1.08× |
| 2022-06-30 | $1.83B | $1.80B | $877.50M | $22.14M | $931.85M | $310.05M | 1.02× |
| 2022-03-31 | $1.96B | $1.86B | $926.12M | $86.75M | $950.89M | $275.67M | 1.05× |
| 2021-12-31 | $2.07B | $1.92B | $1.10B | $71.97M | $897.20M | $230.23M | 1.08× |
| 2021-09-30 | (m) | $1.79B | $1.24B | (m) | $855.04M | $207.12M | (m) |
| 2021-06-30 | (m) | $1.70B | $1.09B | (m) | $808.08M | $178.75M | (m) |
| 2021-03-31 | (m) | $1.39B | $1.13B | (m) | $718.96M | $150.64M | (m) |
| 2020-12-31 | $1.62B | $1.33B | $960.84M | $0.00 | $657.70M | $139.24M | 1.22× |
| 2020-09-30 | $1.24B | $1.12B | $615.53M | $0.00 | $626.05M | $123.09M | 1.11× |
| 2020-06-30 | $877.67M | $941.59M | $404.36M | $0.00 | $473.31M | $131.28M | 0.93× |
| 2020-03-31 | $1.32B | $910.69M | $790.70M | $0.00 | $533.00M | $120.98M | 1.45× |
| 2019-12-31 | $1.42B | $970.97M | $550.42M | $318.20M | $550.29M | $112.05M | 1.46× |
| 2019-09-30 | $1.31B | $870.14M | $490.36M | $292.01M | $531.82M | $94.80M | 1.51× |
| 2019-06-30 | $1.24B | $789.05M | $423.50M | $297.42M | $520.09M | $81.12M | 1.57× |
| 2019-03-31 | $1.21B | $804.88M | $588.00M | $144.54M | $479.28M | $68.49M | 1.51× |
| 2018-12-31 | $1.17B | $692.07M | $636.90M | $98.46M | $439.01M | $55.64M | 1.70× |
| 2018-09-30 | $1.03B | $618.21M | $420.86M | $184.30M | $420.28M | $48.86M | 1.66× |
| 2018-06-30 | $1.09B | $566.65M | $547.99M | $164.63M | $374.37M | $47.25M | 1.92× |
| 2018-03-31 | $1.02B | $517.99M | $498.00M | $164.74M | $361.46M | $35.87M | 1.98× |
| 2017-12-31 | $1.04B | $497.82M | $449.51M | $272.03M | $322.82M | $31.69M | 2.10× |
| 2017-09-30 | $1.00B | $461.37M | $362.61M | $316.45M | $321.33M | $36.94M | 2.17× |
| 2017-06-30 | $893.66M | $424.80M | $358.18M | $243.79M | $291.69M | $35.13M | 2.10× |
| 2017-03-31 | $812.71M | $365.55M | $261.03M | $284.56M | $267.13M | $35.17M | 2.22× |
| 2016-12-31 | $887.67M | $354.33M | $389.27M | $250.98M | $247.41M | $27.13M | 2.51× |
| 2016-09-30 | $857.96M | $343.05M | $419.95M | $193.02M | $244.99M | $26.34M | 2.50× |
| 2016-06-30 | $764.47M | $298.99M | $167.71M | $404.11M | $192.66M | $22.99M | 2.56× |
| 2016-03-31 | $726.08M | $274.75M | $154.42M | $393.66M | $178.00M | $22.62M | 2.64× |
| 2015-12-31 | $685.85M | $271.67M | $167.71M | $359.58M | $158.55M | $19.46M | 2.52× |
| 2015-09-30 | $633.15M | $244.51M | $174.04M | $310.71M | $148.40M | $18.94M | 2.59× |
| 2015-06-30 | $585.01M | $222.93M | $161.75M | $276.79M | $146.47M | $16.41M | 2.62× |
| 2015-03-31 | $582.96M | $200.57M | $189.98M | $254.82M | $138.16M | $14.57M | 2.91× |
| 2014-12-31 | $584.41M | $201.81M | $199.87M | $254.79M | $129.75M | $15.93M | 2.90× |
| 2014-09-30 | $555.54M | $198.56M | $180.68M | $244.82M | $130.05M | $15.98M | 2.80× |
| 2014-06-30 | $496.56M | $187.11M | $167.47M | $198.06M | $131.03M | $13.12M | 2.65× |
| 2014-03-31 | $492.63M | $170.85M | $182.77M | $183.68M | $126.18M | $15.84M | 2.88× |
| 2013-12-31 | $483.24M | $175.34M | $242.95M | $127.04M | $113.25M | $13.97M | 2.76× |
| 2013-09-30 | $432.76M | $163.27M | $175.84M | $147.74M | $109.18M | $14.66M | 2.65× |
| 2013-06-30 | $390.80M | $160.65M | $164.50M | $113.93M | $112.37M | $15.70M | 2.43× |
| 2013-03-31 | $475.39M | $143.85M | $328.75M | $37.98M | $108.67M | $15.44M | 3.30× |
| 2012-12-31 | $433.86M | $155.77M | $306.39M | $28.48M | $98.99M | $15.12M | 2.79× |
| 2012-09-30 | $433.95M | $151.69M | $304.91M | $23.14M | $105.90M | $15.14M | 2.86× |
| 2012-06-30 | $385.70M | $143.84M | $262.80M | $20.75M | $102.15M | $14.62M | 2.68× |
| 2012-03-31 | $334.82M | $135.83M | $224.36M | $16.02M | $94.44M | $13.43M | 2.47× |
| 2011-12-31 | $339.61M | $148.12M | $240.68M | $7.39M | $91.54M | $9.40M | 2.29× |
| 2011-09-30 | $297.06M | $120.19M | $202.23M | $8.19M | $86.65M | $8.28M | 2.47× |
| 2011-06-30 | $257.49M | $109.45M | $168.61M | $6.75M | $82.13M | $6.27M | 2.35× |
| 2011-03-31 | $390.84M | $87.99M | $308.61M | $8.33M | $73.90M | $2.87M | 4.44× |
| 2010-12-31 | $368.71M | $92.97M | $294.66M | $8.62M | $65.43M | $2.54M | 3.97× |
| 2010-09-30 | $336.13M | $80.04M | $264.92M | $7.40M | $63.81M | $2.38M | 4.20× |
| 2010-06-30 | $307.73M | $73.81M | $235.80M | $9.00M | $62.93M | $2.49M | 4.17× |
| 2010-03-31 | (m) | (m) | $190.41M | (m) | (m) | (m) | (m) |
| 2009-12-31 | $241.00M | $81.24M | $166.49M | $19.98M | $54.54M | $2.05M | 2.97× |
| 2009-09-30 | (m) | (m) | $135.96M | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | $122.18M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $87.10M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $89.12M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |